Skip to main content
Canna~Fangled Abstracts

Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours

By September 18, 2022October 4th, 2022No Comments


doi: 10.1016/j.rvsc.2022.09.013.

Online ahead of print.
Affiliations 

Abstract

Cannabinoid receptors (CB1 and CB2) belong to endocannabinoid system (ECS), which is also composed from endocannabinoids and the enzymatic systems involved in their biosynthesis and degradation. The expression of CB1 and CB2 have been previously identified in normal canine mast cell and in atopic dermatitis. Canine cutaneous mast cell tumours (cMCTs) are among the most common cutaneous neoplasms in dogs and have a highly variable clinical behaviour. Expression of CB1-CB2 was assessed by means of immunohistochemistry in thirty-seven dogs (from 2019 to 2021) with proven histological diagnosis of cMCT. Dogs were divided in two groups according to the Kiupel’s grading system: high-grade (HG) cMCT and low-grade (LG) cMCT. A semiquantitative (score 0-3) and quantitative assessment of immunoreactivity (IR) was performed for each case. Our results show that there CB1 and CB2 are highly expressed in LG- cMCT, in contrast to HG- cMCT.

Keywords: Cannabinoid, Dog, Histopathology, Immunohistochemistry, Mast cell tumor

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflicts of interest.

Similar articles

LinkOut – more resources


Leave a Reply